Genetic testing for variants of uncertain significance (VUS) in family members can be a valuable tool in clarifying the clinical implications of a VUS identified in a proband. When a patient receives a VUS result, it indicates a change in their DNA sequence whose impact on health is not yet fully understood. Cascade testing allows healthcare professionals to observe the presence or absence of the same VUS in relatives with or without the associated condition. This observation can provide evidence supporting or refuting the pathogenicity of the variant, ultimately aiding in risk assessment and management for the entire family.
Clarifying the significance of a VUS offers several potential benefits. It can reduce uncertainty and anxiety associated with an ambiguous result, allowing families to make more informed decisions about medical management, including surveillance and preventative measures. It contributes to the growing body of knowledge about genetic variants, improving variant interpretation and clinical care for future patients. Furthermore, as scientific understanding advances, a VUS reclassified as pathogenic or benign can have significant implications for family members who have undergone testing.
